NovoCodex - Web3 Crypto Company Profile, Funding, Valuation, Investors - Cointime

Bitcoin $94,453.26 -3.39%
Ethereum $3,438.06 +2.50%
BNB $642.11 -2.32%
Optimism $2.26 +5.03%
Arbitrum $0.90 +7.52%
Solana $237.37 -5.59%
Polygon $0.55 -0.72%
Cosmos $7.98 -5.46%
Avalanche $41.74 +2.03%

Bitcoin $94,453.26 -3.39%
Ethereum $3,438.06 +2.50%
BNB $642.11 -2.32%
Optimism $2.26 +5.03%
Arbitrum $0.90 +7.52%
Solana $237.37 -5.59%
Polygon $0.55 -0.72%
Cosmos $7.98 -5.46%
Avalanche $41.74 +2.03%

NovoCodex

company

Summary
Funding Rounds
Investors

About

NovoCodex has been engaged in the business of genetic engineering, and cell culture, among others.

Highlights

Total Funding Amount

Details

Last Funding Type: Series A
Last Funding Money Raised: ¥400M
Industries: Clinical Trials,Health Care,Product Research
Founded date: Jan 1, 2015
Operating Status: Active

Funding Rounds

Number of Funding Rounds

Total Funding Amount

1

¥400M

NovoCodex has raised a total of ¥400M in funding over 2 rounds. Their latest funding was raised on Mar 19, 2021 from a Series A round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Mar 19, 2021	Series A	¥400M	1	Lilly Asia Ventures	—	Detail

Investors

Number of Lead Investors

Number of Investors

1

1

NovoCodex is funded by 1 investors. Lilly Asia Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
Lilly Asia Ventures	Yes	Series A